Published in Cell on August 24, 1990
Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci U S A (1991) 6.58
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol (1997) 5.73
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol (1991) 5.49
Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res (1991) 4.39
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev (2007) 3.96
Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage. J Virol (1991) 3.89
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol (1992) 3.85
Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog (2006) 3.67
Substrate specificity of recombinant human immunodeficiency virus integrase protein. J Virol (1991) 3.63
Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J (2001) 3.60
Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc Natl Acad Sci U S A (1992) 3.55
Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res (1993) 3.42
Complementation between HIV integrase proteins mutated in different domains. EMBO J (1993) 3.32
Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J Virol (1993) 3.28
A previously unidentified host protein protects retroviral DNA from autointegration. Proc Natl Acad Sci U S A (1998) 3.10
Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci U S A (1994) 3.04
Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res (1991) 2.93
Retroviral integration into minichromosomes in vitro. EMBO J (1992) 2.85
DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Res (1991) 2.74
The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J Virol (1994) 2.56
DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J (1994) 2.48
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J Virol (1992) 2.40
Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res (1993) 2.32
Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J Virol (1994) 2.26
Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J Virol (1993) 2.22
The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc Natl Acad Sci U S A (1998) 2.21
Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc Natl Acad Sci U S A (1994) 2.20
Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J Virol (1991) 2.16
Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J Virol (1999) 2.13
A stable complex between integrase and viral DNA ends mediates human immunodeficiency virus integration in vitro. Proc Natl Acad Sci U S A (1994) 2.10
Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro. J Virol (1990) 2.06
Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. J Virol (1992) 2.02
The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog (2008) 2.00
Repair of gaps in retroviral DNA integration intermediates. J Virol (2000) 2.00
HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res (2005) 1.96
A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J (1997) 1.94
Identification of residues in the Mu transposase essential for catalysis. Proc Natl Acad Sci U S A (1994) 1.94
Nonrandom integration of retroviral DNA in vitro: effect of CpG methylation. Proc Natl Acad Sci U S A (1992) 1.94
Relationship of avian retrovirus DNA synthesis to integration in vitro. Mol Cell Biol (1991) 1.92
Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. J Virol (1995) 1.87
Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. J Virol (1994) 1.84
An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol (1994) 1.81
Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis. Nucleic Acids Res (1993) 1.79
Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J (2001) 1.77
The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J Virol (2003) 1.76
Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase. J Virol (1992) 1.74
HIV DNA integration. Cold Spring Harb Perspect Med (2012) 1.73
Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J Virol (1996) 1.72
A rapid in vitro assay for HIV DNA integration. Nucleic Acids Res (1991) 1.65
Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.65
Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis. J Virol (1991) 1.62
Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc Natl Acad Sci U S A (1996) 1.62
Transposase-induced excision and circularization of the bacterial insertion sequence IS911. EMBO J (1992) 1.62
A covalent complex between retroviral integrase and nicked substrate DNA. Proc Natl Acad Sci U S A (1991) 1.61
Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors. J Virol (2002) 1.56
Tethering human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J Virol (1997) 1.56
Identification and characterization of a pre-cleavage synaptic complex that is an early intermediate in Tn10 transposition. EMBO J (1995) 1.55
Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase. J Virol (1999) 1.52
Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites. Proc Natl Acad Sci U S A (1992) 1.52
Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol (1996) 1.50
Integrase, LEDGF/p75 and HIV replication. Cell Mol Life Sci (2008) 1.50
A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acids Res (1994) 1.47
Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. J Virol (1996) 1.44
Cheminformatics methods for novel nanopore analysis of HIV DNA termini. BMC Bioinformatics (2006) 1.42
Nuclear landscape of HIV-1 infection and integration. Nat Rev Microbiol (2016) 1.41
Modulation of activity of Moloney murine leukemia virus preintegration complexes by host factors in vitro. J Virol (1998) 1.40
Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions. J Virol (1998) 1.40
Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. Nucleic Acids Res (1994) 1.40
Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J Virol (1995) 1.38
Structural biology of retroviral DNA integration. Virology (2011) 1.37
Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli. J Virol (1994) 1.35
Retroviral integration: in vitro host site selection by avian integrase. J Virol (1994) 1.33
In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc Natl Acad Sci U S A (1995) 1.32
Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles. EMBO J (1992) 1.32
Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase. Nucleic Acids Res (1994) 1.29
Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase. Proc Natl Acad Sci U S A (1996) 1.28
Multiple complex families of endogenous retroviruses are highly conserved in the genus Gallus. J Virol (1992) 1.28
Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. Nucleic Acids Res (1993) 1.27
Comparison of DNA binding and integration half-site selection by avian myeloblastosis virus integrase. J Virol (1993) 1.26
High-resolution functional mapping of a cloned gene by genetic footprinting. Proc Natl Acad Sci U S A (1997) 1.25
Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol (1993) 1.25
Methods for integration site distribution analyses in animal cell genomes. Methods (2008) 1.21
Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J Virol (1991) 1.21
Requirement for a conserved serine in both processing and joining activities of retroviral integrase. Proc Natl Acad Sci U S A (1992) 1.20
A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res (1991) 1.19
Retroviral cDNA integration: stimulation by HMG I family proteins. J Virol (2000) 1.19
Artificial mobile DNA element constructed from the EcoRI endonuclease gene. Proc Natl Acad Sci U S A (1992) 1.17
An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA. J Virol (2003) 1.16
DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J Virol (1994) 1.15
Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob Agents Chemother (1995) 1.15
Different roles of bases within the integration signal sequence of human immunodeficiency virus type 1 in vitro. J Virol (1995) 1.15
Retroviral DNA integration directed by HIV integration protein in vitro. Science (1990) 5.87
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J (2000) 4.55
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell (1995) 4.25
Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest (1998) 3.76
Artificial surfactant therapy in hyaline-membrane disease. Lancet (1980) 3.21
Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem (1982) 3.11
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Bni1p implicated in cytoskeletal control is a putative target of Rho1p small GTP binding protein in Saccharomyces cerevisiae. EMBO J (1996) 2.87
The 2.8 A structure of hydroxylamine oxidoreductase from a nitrifying chemoautotrophic bacterium, Nitrosomonas europaea. Nat Struct Biol (1997) 2.81
Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation (1999) 2.80
Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J Virol (1998) 2.79
The arcB gene of Escherichia coli encodes a sensor-regulator protein for anaerobic repression of the arc modulon. Mol Microbiol (1990) 2.71
Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci U S A (1999) 2.69
Nucleotide sequence of the hag gene encoding flagellin of Escherichia coli. J Bacteriol (1986) 2.68
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62
De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology (2009) 2.53
"Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling. Circulation (1998) 2.43
The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun (1998) 2.41
Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell (1999) 2.26
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21
Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res (2001) 2.06
p32 protein, a splicing factor 2-associated protein, is localized in mitochondrial matrix and is functionally important in maintaining oxidative phosphorylation. J Biol Chem (1997) 2.03
Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res (2000) 2.00
Molecular characterization of a functional cDNA for rat substance P receptor. J Biol Chem (1989) 1.91
Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology (2002) 1.82
Dynamic localization and function of Bni1p at the sites of directed growth in Saccharomyces cerevisiae. Mol Cell Biol (2001) 1.79
Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res (1998) 1.78
Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J (2001) 1.77
Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood (2000) 1.76
Functional expression of furin demonstrating its intracellular localization and endoprotease activity for processing of proalbumin and complement pro-C3. J Biol Chem (1991) 1.76
Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet (2000) 1.71
Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics (1999) 1.64
Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science (2000) 1.64
Proteolipid in bovine lung surfactant: its role in surfactant function. Biochem Biophys Res Commun (1986) 1.62
Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol (2003) 1.60
Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation (1996) 1.60
Shs1p: a novel member of septin that interacts with spa2p, involved in polarized growth in saccharomyces cerevisiae. Biochem Biophys Res Commun (1998) 1.58
Complications after cyst excision with hepaticoenterostomy for choledochal cysts and their surgical management in children versus adults. J Pediatr Surg (1997) 1.56
Mucinous cystic tumor of the retroperitoneum. A report of two cases. Acta Cytol (1994) 1.56
Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli. Infect Immun (1985) 1.55
Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun (1984) 1.55
Intracellular localization of 8-oxo-dGTPase in human cells, with special reference to the role of the enzyme in mitochondria. J Biol Chem (1995) 1.52
Endothelial gaps: time course of formation and closure in inflamed venules of rats. Am J Physiol (1997) 1.50
Repair of scalp defects using a tissue expander and Marlex mesh. Plast Reconstr Surg (1992) 1.48
Thioredoxin h is one of the major proteins in rice phloem sap. Planta (1995) 1.47
Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J Exp Med (1996) 1.46
Effects of sulfate concentrations on the expression of a soybean seed storage protein gene and its reversibility in transgenic Arabidopsis thaliana. Plant Cell Physiol (1995) 1.44
Development of synthetic lung surfactants. J Lipid Res (1986) 1.44
Microbiological degradation of bile acids. Ring A cleavage and 7alpha, 12alpha-dehydroxylation of cholic acid by Arthrobacter simplex. Biochem J (1969) 1.44
New dehydroxylation reaction observed in the microbiological degradation pathway of cholic acid. Nature (1967) 1.43
Simplified nonlinearity correction of oxygen-15-water regional cerebral blood flow images without blood sampling. J Nucl Med (1994) 1.43
Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr (1994) 1.42
Rice phloem thioredoxin h has the capacity to mediate its own cell-to-cell transport through plasmodesmata. Planta (1998) 1.42
Adriamycin instillation therapy for bladder tumors. Tohoku J Exp Med (1979) 1.38
Evidence for p53-mediated modulation of neuronal viability. J Neurosci (1996) 1.37
Aluminum-induced 1-->3-beta-D-glucan inhibits cell-to-cell trafficking of molecules through plasmodesmata. A new mechanism of aluminum toxicity in plants. Plant Physiol (2000) 1.36
Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen. Nucleic Acids Res (2001) 1.35
Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics (1996) 1.35
bor1-1, an Arabidopsis thaliana mutant that requires a high level of boron. Plant Physiol (1997) 1.34
Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother (2000) 1.34
Membrane localization, topology, and mutual stabilization of the rnfABC gene products in Rhodobacter capsulatus and implications for a new family of energy-coupling NADH oxidoreductases. Biochemistry (1997) 1.32
Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. J Bacteriol (1997) 1.32
Carcinoembryonic antigen family receptor specificity of Neisseria meningitidis Opa variants influences adherence to and invasion of proinflammatory cytokine-activated endothelial cells. Infect Immun (2000) 1.31
Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett (2001) 1.30
Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res (1998) 1.29
Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging. Eur J Nucl Med (1998) 1.28
Prophyromonas gingivalis fimbriae mediate coaggregation with Streptococcus oralis through specific domains. J Dent Res (1997) 1.26
Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3. Genes Chromosomes Cancer (1998) 1.26
Amino-acid conjugation in bacteria. Nature (1968) 1.26
Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins. Infect Immun (1996) 1.25
Studies on the structure of polysaccharides from the bark of Melia azadirachta. Chem Pharm Bull (Tokyo) (1982) 1.24
HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res (2000) 1.24
Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med (2000) 1.24
Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites. Antivir Chem Chemother (1999) 1.23
Microbiological degradation of bile acids. The preparation of some hypothetical metabolites involved in cholic acid degradation. Biochem J (1976) 1.23
Contributions of three glycosyltransferases to sucrose-dependent adherence of Streptococcus mutans. J Dent Res (2001) 1.23
Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP). Biochim Biophys Acta (1997) 1.22
Expression and functional role of syntaxin 1/HPC-1 in pancreatic beta cells. Syntaxin 1A, but not 1B, plays a negative role in regulatory insulin release pathway. J Biol Chem (1996) 1.22
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene (2001) 1.22
Hepaticoenterostomy after excision of choledochal cyst in children: a 30-year experience with 180 cases. J Pediatr Surg (1996) 1.20
Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod (2010) 1.19
Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor. HIV Clin Trials (2013) 1.18
Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience (2004) 1.18
Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med (1990) 1.18
Application of laser tweezers to studies of the fences and tethers of the membrane skeleton that regulate the movements of plasma membrane proteins. Methods Cell Biol (1998) 1.17
18F-FDG PET imaging of muscle activity in runners. J Nucl Med (1999) 1.17
Syntaxin 1 (HPC-1) is associated with chromaffin granules. J Biol Chem (1995) 1.17
Temperature change in human muscle during and after pulsed short-wave diathermy. J Orthop Sports Phys Ther (1999) 1.17
Cytosine arabinoside bladder instillation therapy for bladder tumors. Tohoku J Exp Med (1982) 1.17
Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr Res (1978) 1.16
Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. J Infect Dis (1984) 1.16
Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl(-) currents. J Clin Invest (2000) 1.16
Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation. Genes Cells (1997) 1.16
An FH domain-containing Bnr1p is a multifunctional protein interacting with a variety of cytoskeletal proteins in Saccharomyces cerevisiae. Oncogene (1999) 1.16
Different roles of bases within the integration signal sequence of human immunodeficiency virus type 1 in vitro. J Virol (1995) 1.15
Patent ductus venosus with hypoplastic right hepatoportal system in a young child born with asymmetric intra-uterine growth retardation. Eur J Pediatr (1992) 1.15
Identification and molecular characterization of a gene homologous to epr (endopeptidase resistance gene) in Staphylococcus aureus. Gene (1998) 1.13